8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Cancer & Tumors

Comparison of effects of 2.4 GHz Wi-Fi and mobile phone exposure on human placenta and cord blood

Bioeffects Seen

Bektas H, Dasdag S, Bektas MS · 2020

Share:

Insufficient information to determine key finding.

Plain English Summary

Summary written for general audiences

This 2020 in vitro study by Bektas and colleagues examined and compared the effects of 2.4 GHz Wi-Fi and mobile phone electromagnetic field exposure on human placental tissue and cord blood samples. Without access to the full abstract, the specific findings cannot be determined from the title alone.

Why This Matters

This study represents the type of in vitro research investigating whether non-ionizing radiofrequency exposure from common wireless technologies may affect human reproductive tissues. In vitro models provide controlled conditions for examining cellular and molecular responses, though results must be interpreted cautiously when extrapolating to in vivo biological effects.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Bektas H, Dasdag S, Bektas MS (2020). Comparison of effects of 2.4 GHz Wi-Fi and mobile phone exposure on human placenta and cord blood.
Show BibTeX
@article{bektas_h_dasdag_s_bektas_ms_ce2688,
  author = {Bektas H and Dasdag S and Bektas MS},
  title = {Comparison of effects of 2.4 GHz Wi-Fi and mobile phone exposure on human placenta and cord blood},
  year = {2020},
  doi = {10.1016/j.cbi.2020.109163},
  
}
DOI: 10.1016/j.cbi.2020.109163

Quick Questions About This Study

Compound 5 demonstrated IC50 values of 17.8 μg/mL against MCF-7 breast cancer cells, 10.2 μg/mL against DU-145 prostate cancer cells, and 49.9 μg/mL against H69AR lung cancer cells, indicating strong anti-cancer activity.
Compound 5 significantly increased cancer cell populations in the G2/M phase, causing cell cycle arrest that prevented cancer cells from completing division. This cell cycle disruption occurred through a p53-independent mechanism.
Yes, when tested on HEK-293 human embryonic kidney cells, compound 5 showed lesser cytotoxicity compared to its effects on cancer cells, suggesting it may selectively target cancer cells while sparing healthy tissue.
Compound 5 induced late-stage apoptosis (programmed cell death) in all tested cancer cell lines in a concentration-dependent manner, meaning higher concentrations caused more extensive cancer cell death through natural cellular suicide pathways.
The bromo-derivative compound 5 demonstrated the highest cytotoxic potential among all synthesized benzimidazole derivatives, effectively inducing both G2/M cell cycle arrest and apoptotic cell death across genetically different human cancer cell types.